Terapia endovascular en el sindrome de vena cava superior: caso clínico

dc.creatorBoza W,Camilo
dc.creatorMertens M,Renato
dc.creatorValdés E,Francisco
dc.creatorKramer Sch,Albrecht
dc.creatorMariné M,Leopoldo
dc.creatorVergara G,Jeanette
dc.date2001-04-01
dc.date.accessioned2017-03-07T15:13:51Z
dc.date.available2017-03-07T15:13:51Z
dc.identifierhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000400011
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/380636
dc.descriptionThe treatment of superior vena cava syndrome is usually oriented to the underlying cause, that can be too slow in emergency cases. We report a 49 years old woman with a multiple myeloma that was admitted due to a superior vena cava syndrome caused by a central venous catheter used for chemotherapy for 20 weeks. She was successfully treated with thrombolysis, angioplasty and stent placement. The patient died 7 months later due to the underlying disease. Long term catheters are the responsible for 20 to 30% of superior vena cava syndromes. Endovascular treatment of the syndrome is successful in 60 to 100% of cases with a symptomatic relapse in 4 to 45% of patients. (Rev Méd Chile 2001; 129: 421-6)
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.sourceRevista médica de Chile v.129 n.4 2001
dc.subjectCatheterization, central venous
dc.subjectCatheterization, peripheral
dc.subjectSuperior vena cava syndrome
dc.titleTerapia endovascular en el sindrome de vena cava superior: caso clínico
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución